Skip to main content
Full access
Ask the Expert
Published Online: 16 January 2023

The Entanglements of Substance Use Disorders and Emergency Departments

Is the emergency department the appropriate place for patients with substance use disorders to access treatment?
Emergency departments (EDs) across the United States are increasingly called on to care for patients with substance use disorders (1). As the nation faced a pandemic in 2020, general ED visits decreased, but visits for mental health conditions and substance use disorders showed a relative increase (2). Despite presenting to EDs in such high numbers, according to the National Survey on Drug Use and Health, in 2019, only 1.5% (4.2 million people) received any treatment for substance use disorders in the previous year, and only 514,000 identified the emergency room as the location where they received treatment (3). EDs across the country have responded by creating amazing ways to engage patients with substance use disorders, initiate treatment, and refer them to additional treatment (4, 5).
Patients who present to EDs seeking treatment for their substance use disorder face an uphill battle. They are presenting with conditions that are not viewed by many health care providers as an “emergency,” and face health care workers who may have a negative attitude toward substance use (6). Several studies have shown that staff feel unprepared and struggle to show empathy to patients with substance use disorders (7, 8). A 2008 paper based on thousands of observed interactions in a California ED identified several prominent themes, such as the following: Providers were concerned about drug-seeking behavior, and they had to balance the needs of substance-involved patients with the necessity to manage limited resources. There have been many attempts to combat these challenges and engage staff in the care of patients with substance use disorders who are in treatment in EDs. Educational experiences, and even communicating positive stories about recovery to staff, have been found to be effective in reducing the stigma of substance use disorders (9). Peer supports or recovery coaches have been used in a variety of settings and have shown great potential in substance treatment centers (10). The use of peer supports in EDs is a newer implementation, and a recent large randomized controlled trial found them to be as effective as clinical social workers in engaging substance use disorder treatment (11).
Patients using substances present to EDs for various reasons, but unless they identify their substance use as a problem, it may go unrecognized. There are several validated tools for screening substance use disorders, but adapting them for use in an ED that may not offer a private area for discussion can make their use challenging. The greatest advances in screening tools for use in the ED involve screening for alcohol use disorder. The CAGE (Cut down, Annoyed, Guilty, Eye-opener) questionnaire has been in use since the 1980s (12), and the Alcohol Use Disorders Identification Test-Concise (13) is a tool frequently used to assess alcohol use. For other substance use disorders, the single screening test question “How many times in the past year have you used an illegal drug or used a prescription drug for a nonmedical reason?” was found to be 100% sensitive and 73.5% specific in a Boston primary care setting, and it may be adaptable to the ED setting (14).
EDs are in a unique position to possibly start treatment for substance use disorders and connect patients directly to ongoing treatment. Interventions in the ED can range from brief motivational interviewing to the administration of medication. Brief interventions have been shown to be effective in reducing alcohol consumption and harmful events in primary care, inpatient, and ED settings (15). The length of time of the intervention varies tremendously throughout the studies of brief interventions, but it is notable that even 5 minutes of simple advice and counseling was shown to be effective (16). The SBIRT (screening, brief intervention, and referral to treatment) model has been studied in EDs and has shown significant reductions in at-risk drinking up to 3 months postintervention (17). The most exciting evidence for treatment options is ED-initiated treatment for opioid use disorder. In a 2015 study, the authors found that 78% of the patients initiated on buprenorphine remained in treatment at 30 days, as did 45% of patients receiving a brief intervention and 37% that received a referral (18). Following this publication, many EDs have begun to use protocols to initiate treatment for opioid use disorders in EDs, and the practice was further solidified by the “Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department,” a document approved by the board of directors of the American College of Emergency Physicians (19). The referral to more definitive substance treatment from the ED is something that will vary from system to system and from state to state on the basis of resources and availability but could include 12-step programs, withdrawal management treatment, residential treatment, or intensive outpatient treatment. Recovery coaches, peers, health promotion advocates, and patient navigators have all been helpful in improving connections to substance treatment facilities after discharge from the ED (2022).
As the recipients of millions of patients, EDs are uniquely positioned to identify and guide patients with substance use disorders to treatment, and we owe it to them to have evidence-based options and provide them the best care. There are many great options, but more research is needed to give us more tools; in doing so, however, we have a tremendous opportunity to improve the lives of patients with substance use disorder.

References

1.
Preliminary Findings from Drug-Related Emergency Department Visits, 2021: Drug Abuse Warning Network (HHS Publication No. PEP22-07-03-001), Rockville, MD, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2022. https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP22-07-03-001.pdf
2.
Holland KM, Jones C, Vivolo-Kantor AM, et al: Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiatry 2021; 78:372–379
3.
Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2020. https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm
4.
D’Onofrio G, Chawarski MC, O’Connor PG, et al: Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med 2017; 32:660–666
5.
Gormley MA, Pericot-Valverde I, Diaz L, et al: Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: a systematic review. Drug Alcohol Depend 2021; 229:109123
6.
Mendiola CK, Galetto G, Fingerhood M: An exploration of emergency physicians’ attitudes toward patients with substance use disorder. J Addict Med 2018; 12:132–135
7.
Ahern J, Stuber J, Galea S: Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend 2007; 88:188–196
8.
Miller NS, Sheppard LM, Colenda CC, et al: Why physicians are unprepared to treat patients who have alcohol and drug related disorders. Acad Med 2001; 76:410–418
9.
Livingston JD, Milne T, Fang ML, et al: The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction 2012; 107:39–50
10.
Eddie D, Hoffman L, Vilsaint C, et al: Lived experience in new models of care for substance use disorder: a systematic review of peer recovery support services and recovery coaching. Front Psychol 2019; 10:1052
11.
Beaudoin FL, Jacka BP, Li Y, et al: Effect of a peer-led behavioral intervention for emergency department patients at high risk of fatal opioid overdose: a randomized clinical trial. JAMA Netw Open 2022; 5:e2225582
12.
O’Brien CP: The CAGE questionnaire for detection of alcoholism: a remarkably useful but simple tool. JAMA 2008; 300:2054–2056
13.
Bush K, Kivlahan DR, McDonell MB, et al: The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med 1998; 158:1789–1795
14.
Smith PC, Schmidt SM, Allensworth-Davies D, et al: A single-question screening test for drug use in primary care. Arch Intern Med 2010; 170:1155–1160
15.
D’Onofrio G, Degutis LC: Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review. Acad Emerg Med 2002; 9:627–638
16.
Babor TF, Grant M (eds): Project on Identification and Management of Alcohol-Related Problems. Report on Phase II: A Randomized Clinical Trial of Brief Interventions in Primary Health Care. Geneva, World Health Organization, 1992
17.
Academic ED SBIRT Research Collaborative: The impact of screening, brief intervention and referral for treatment in emergency department patients’ alcohol use: a 3-, 6- and 12-month follow-up. Alcohol Alcohol 2010; 45:514–519
18.
D’Onofrio G, O’Connor PG, Pantalon MV, et al: Emergency department–initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA 2015; 313:1636–1644
19.
Hawk K, Hoppe J, Ketcham E, et al: Consensus recommendations on the treatment of opioid use disorder in the emergency department. Ann Emerg Med 2021; 78:434–442
20.
Ware OD, Buresh ME, Irvin NA, et al: Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department. Drug Alcohol Depend Rep 2022; 5:100093.Web
21.
D’Onofrio G, Degutis LC: Integrating Project ASSERT: a screening, intervention, and referral to treatment program for unhealthy alcohol and drug use into an urban emergency department. Acad Emerg Med 2010; 17:903–911
22.
Bogan C, Jennings L, Haynes L, et al: Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state. J Subst Abuse Treat 2020; 112S:73–78

Information & Authors

Information

Published In

History

Published in print: Winter 2023
Published online: 16 January 2023

Keywords

  1. Emergency Psychiatry
  2. Drug abuse

Authors

Details

David Pepper, M.D. [email protected]
Institute of Living, Hartford Hospital, Hartford, Connecticut.

Notes

Send correspondence to Dr. Pepper ([email protected]).

Competing Interests

Dr. Pepper reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share